3Dzierzbicka K, Kolodziejczyk A M. Adjuvants-essential components of new generation vaccines. Postepy Biochem, 2006, 52(2) :204-211.
4Korn T, Bettelli E, Oukka M, et al. IL-17 and Thl7 Cells. Annu Rev Immunol, 2009,27( 1 ) : 485-517.
5Murugaiyan G, Mittal A, Weiner H L. Increased osteopontin expression in dendritic cells amplifies IL-17 production by CD4+ T cells in experimental autoimmune encephalomyelitis and in multiple sclerosis. J Immunol, 2008, 181 (11) : 7480-7488.
6Wong C K, Lit L C, Tam L S, et al. Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for ThlT-mediated inflammation in auto-immunity. Clin Immunol, 2008,127(3) : 385-393.
7Kehlen A, Thiele K, Riemann D, et al. Expression, modulation and signalling of IL-17 receptor in fibroblast-like synoviocytes of patients with rheumatoid arthritis. Clin Exp Immunol, 2002,127 (3) : 539-546.
8Garley M, Jablonska E, Grabowska S Z, et al. IL-17 family cytokines in neutrophils of patients with oral epithelial squamouscell carcinoma. Neoplasma, 2009,56(2) : 96-100.
9Arican O, ArM M, Sasmaz S, et al. Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators Inflamm, 2005,2005 ( 5 ) : 273-279.
10Ma D, Zhu X, Zhao P, et al. Profile of Thl7 cytokines (IL-17, TGF-beta, IL-6) and Thl cytokine (IFN-gamma) in patients with immune thromboeytopenic purpura. Ann Hematol, 2008,87 ( 11 ) : 899-904.
